Standard transaction agreement proves ineffective at pharmacies

Published: 2003-03-12 06:57:00

Updated: 2003-03-12 06:57:00

The current standard transaction agreement designed to ensure more efficient dealings between pharmaceutical firms and pharmacies, which was revised by the Korea Pharmaceutical Association last December, has actually failed to revamp the prevailing unfair transaction practices including drug inve...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK